Q3 2013

Filed Nov 1, 2013 · 10-Q · 32 days after period end · 0001069530-13-000005

Q3 2013 · 10-Q

Revenue

$1.96M

−28.1% vs Q3 2012

Net Income

-$762.00K

N/M vs Q3 2012

EPS Diluted

-$0.02

N/M vs Q3 2012

Operating Income-$776,000N/M

Operating Cash Flow

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$1.96M	$2.73M	$2.75M	$2.90M
Net Income	-$762.00K	-$1.55M	-$815.00K	-$1.03M
EPS Diluted	-$0.02	-$0.03	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR